7 Cheap Drug Companies with Solid Dividends

Long-term treasury bonds are ridiculously expensive. It may be OK to buy them now and sell them at a small premium to Federal Reserve but we don’t think it is a good idea to invest them for the long-term. High dividend yielding stocks are much better alternatives despite the higher volatility. The demand for healthcare and pharmaceuticals will probably be there in 30 years. So, we think investors should consider investing in the following 7 cheap drug companies with solid dividends:

RENAISSANCE TECHNOLOGIES

1.  Eli Lilly & Co. (LLY) is trading at $38.23, near its 52-week high of $39.78. LLY is a strong buy. It is priced at 8.96 times its earning and has an EPS of 4.25. It is a $42.45B market cap company and offers a dividend yield of 5.10%. LLY is a favorite pick of Jim Simons’ Renaissance Technologies. The fund has a position worth more than $387 million in the company after increasing its stake by 59% in the second quarter.

2.  Bristol-Myers Squibb Company (BMY) recently traded at $32.31 a share, near its 52-week high of $33.20 a share. It has a $55.16B market cap and carries a 4.10% dividend yield. BMY has a 16.77 P/E ratio and an EPS of 1.93. Jim Simons also likes BMY. He increased his fund’s position in the company by 53% in the second quarter, bring its total position to a value over $207 million. Of the funds we track, the next most bullish fund manager is Samuel Isaly. His Orbimed Advisors has a $142 million position in BMY (see Samuel Isaly’s favorite stocks).

3.  AstraZeneca PLC (AZN) is trading at $46.66 a share. Analysts forecast the stock will reach $51.55 within the next 12 months. This $63.74B market cap company is trading at 8.07 times its earnings and has an EPS of 5.78. Jim Simons is bullish on this stock too. He has almost $28 million invested in the company, and he isn’t alone. David Dreman’s Dreman Value Management fund has more than $23.2 million invested in AZN (see more of David Dreman’s top picks).

4.  Sanofi-Aventis (SNY) recently traded at $34.53. It is expected to increase to $44.22 a share within the next year. As an added bonus, SNY offers a 3.70% dividend yield. The $92.69B market cap company has a P/E ratio of 15.27 and an EPS of 2.26. Ken Fisher of Fisher Asset Management is extremely bullish on this stock. His fund holds a stake worth more than $592.5 million in the company, totaling around 1.5% of the Fisher Asset Management portfolio (check out more of Ken Fisher’s favorite stocks).

5.  Merck & Co. Inc. (MRK) offers a 4.60% dividend yield. The $100.34B market cap company recently traded at $32.57. Analysts expect the stock to rise to $39.60 within the next 12 months. It has a 35.10 P/E ratio and a 0.93 EPS. Ric Hill’s Diamond Hill Capital fund has more than 2% of its portfolio invested in MRK. Its position is currently valued at $172.8 million (read about Ric Dillon’s other top picks).

6.  GlaxoSmithKline plc (GSK) is trading at $43.12 a share. Analysts predict the stock will hit $50.58 within the next 12 months. The $110.17B market cap company offers a 4.80% dividend yield. It has a P/E ratio of 21.67 and an EPS of 1.99. Several big names are bullish on this stock. Ken Fisher has a stake worth more than $500 million in GSK after increasing his fund’s position in the company by 134% in the second quarter. David Dreman is also bullish on GSK, as is Berkshire Hathaway’s Warren Buffett. His fund has $64.8 million invested in the company (see Warren Buffett’s favorite positions).

7.  Pfizer Inc. (PFE) recently traded at $18.81 a share. It offers a 4.20% dividend yield and is expected to top $23.28 a share within a year. PFE has a $146.77B market cap. It is trading at 17.56 times its earning and has an EPS of 1.07. PFE is a top pick for David Einhorn. The notoriously savvy fund manager, famous for his predictions, has more than 10% of his Greenlight Capital fund invested in PFE (see David Einhorn’s top picks).

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!